Results

Bristol-Myers Squibb Company

07/30/2021 | Press release | Distributed by Public on 07/30/2021 05:01

Bristol Myers Squibb Receives European Commission Approval for Opdivo (nivolumab) as Adjuvant Treatment for Esophageal or Gastroesophageal Junction Cancer Patients with[...]